Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Iron Metabolism before Allo-HSCT in Patients with Acute Leukemia and Impact of Iron Overload on Transplantation

Jimin Shi, Xuying Pei, Yi Luo, Yamin Tan, Yanmin Zhao, Jingsong He, Weiyan Zheng, Xiaoyu Lai, Gaofeng Zheng, Jie Zhang, Maofang Lin, Zhen Cai, He Huang, MD PhD

Blood (2016) 128 (22): 2461.

https://doi.org/10.1182/blood.V128.22.2461.2461

Published: 2016

Journal Articles

Imatinib Combined with Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Versus Imatinib Alone for Young Patients with Chronic Myeloid Leukemia in Chronic Phase

Yanmin Zhao, Yi Luo, Yamin Tan, Jimin Shi, Zhen Cai, MDPhD, Maofang Lin, He Huang, MDPhD

Blood (2014) 124 (21): 4568.

https://doi.org/10.1182/blood.V124.21.4568.4568

Published: 2014

Journal Articles

Serem Ferritin Was the Only Prognostic Factor for Disease Free Survival in MDS Patients after Allo-HSCT: A Single Centre Study

Jimin Shi, Yi Luo, Yamin Tan, Yu Lin, Zhen Cai, Maofang Lin, He Huang, MD PhD

Blood (2014) 124 (21): 5859.

https://doi.org/10.1182/blood.V124.21.5859.5859

Published: 2014

Journal Articles

Relationship between Gene Polymorphism of Recipient/ Donor Immune Pathway and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Jimin Shi, Haowen Xiao, Yi Luo, Yamin Tan, Jingsong He, PhD, Wanzhuo Xie, Xiujin Ye, Zhen Cai, Maofang Lin, He Huang, MDPhD

Blood (2014) 124 (21): 3871.

https://doi.org/10.1182/blood.V124.21.3871.3871

Published: 2014

Journal Articles

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

Yi Luo, Haowen Xiao, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Weiyan Zheng, Yuanyuan Zhu, Xiujin Ye, Xiaohong Yu, Zhen Cai, Maofang Lin, He Huang

Blood (2014) 124 (17): 2735–2743.

https://doi.org/10.1182/blood-2014-04-571570

Published: 2014

Journal Articles

Clinical Outcome Of R-CHOP Or CHOP Regimen For Elderly Patients With Diffuse Large B-Cell Lymphoma In China：A Single Center’s Experience

Yajian Jiang, M.B.B.S., De Zhou, M.D., Wanzhuo Xie, M.D. Ph.D., Jingsong He, MD, PhD, Jimin Shi, M.D., Yi Luo, M.D., Jie Zhang, M.D., Maofang Lin, M.D, Ph.D, Xiujin Ye, M.D., Zhen Cai, M.D., He Huang, MD, PhD

Blood (2013) 122 (21): 5098.

https://doi.org/10.1182/blood.V122.21.5098.5098

Published: 2013

Journal Articles

Prospective Evaluation Of Allo-HSCT From Haploidentical-Related Donors Compared With Matched Sibling Donors and Unrelated Donors For Patients With Hematological Malignancies: Results From An Open-Label Trial

Yi Luo, Haowen Xiao, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, MD, PhD, Wanzhuo Xie, M.D. Ph.D., Weiyan Zheng, M.D., Yuanyuan Zhu, Xiujin Ye, M.D. Ph.D., Zhen Cai, MD, Maofang Lin, He Huang

Blood (2013) 122 (21): 3338.

https://doi.org/10.1182/blood.V122.21.3338.3338

Published: 2013

Journal Articles

Clinical Characteristics and Outcome of Isolated Extramedullary Relapse in Acute Leukemia Following Allogeneic Stem Cell Transplantation: A Single Institutional Analysis

Jimin Shi, M.D., Ph.D., Xiaojian Meng, Ph.D, Yi Luo, Yamin Tan, Xiaoli Zhu, Gaofeng Zheng, M.Med, Jingsong He, Weiyan Zheng, Ph.D., Wanzhuo Xie, M.D., Ph.D., Li Li, M.Med, Xiujin Ye, M.D., Ph.D., Jie Zhang, M.Med, Zhen Cai, Maofang Lin, He Huang

Blood (2012) 120 (21): 4211.

https://doi.org/10.1182/blood.V120.21.4211.4211

Published: 2012

Journal Articles

Significance of Clinical Factors As Prognostic Indicators for Mature T-Cell Non-Hodgkin Lymphoma Patients: A Retrospective Analysis of Chinese Cases

Wanzhuo Xie, M.D. Ph.D., Keyue Hu, Fan Xu, De Zhou, Weijia Huang, M.Med, Li Li, M.Med, Jingsong He, Jimin Shi, Yi Luo, Jingjing Zhu, Guoqing Wei, Ph.D., Jie Zhang, M.Med, Maofang Lin, Xiujin Ye, M.D., Ph.D., Zhen Cai, He Huang

Blood (2012) 120 (21): 5093.

https://doi.org/10.1182/blood.V120.21.5093.5093

Published: 2012

Journal Articles

Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients

Jingsong He, M.D., Ph.D., Li Yang, M.Med, Dian Jin, M.Med, Xuanru Lin, M.Med, Qianqian Yang, M.Med, Xiaoyan Han, M.Med, Gaofeng Zheng, M.Med, Weiyan Zheng, Ph.D., Guoqing Wei, Ph.D., Wenjun Wu, M.Med, Xiujin Ye, M.D., Ph.D., Jimin Shi, M.D., Ph.D., Wanzhuo Xie, M.D., Ph.D., Jie Zhang, M.Med, Maofang Lin, M. D, Ph.D, He Huang, M.D., Ph.D., Zhen Cai, M.D., Ph.D.

Blood (2012) 120 (21): 5048.

https://doi.org/10.1182/blood.V120.21.5048.5048

Published: 2012

Journal Articles

Donor Toll-Like Receptor 9 Genetic Factors in Susceptibility to Acute Graft-Versus-Host Disease and Cytomegalovirus Infection After Related and Unrelated Hematopoietic Stem Cell Transplantation

Haowen Xiao, Yi Luo, Xiaoyu Lai, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, M.D. Ph.D., Weiyan Zheng, Ph.D., Li-Mengmeng Wang, Shan Fu, Lifei Zhang, Xiujin Ye, M.D. Ph.D., Xiaohong Yu, Zhen Cai, Maofang Lin, He Huang, M.D.; Ph.D.

Blood (2012) 120 (21): 1938.

https://doi.org/10.1182/blood.V120.21.1938.1938

Published: 2012

Journal Articles

Genetic Variation in the Effector Pathways of Cytotoxic T Lymphocytes Influences Alloimmune Reactivities Following Allogeneic Hematopoietic Stem Cell Transplantation

Haowen Xiao, Yi Luo, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, MD, Xiujin Ye, Zhen Cai, Maofang Lin*, He Huang

Blood (2011) 118 (21): 3054.

https://doi.org/10.1182/blood.V118.21.3054.3054

Published: 2011

Journal Articles

Combination therapy based on bortezomib for 102 patients with newly-diagnosed multiple myeloma: a Chinese experience

Jingsong He, Li Yang, Xiaoyan Han, Gaofeng Zheng, Xiaojian Meng, Guoqing Wei, Wenjun Wu, Weiyan Zheng, Xiujin Ye, Jimin Shi, Wanzhuo Xie, Jie Zhang, He Huang, Maofang Lin, Zhen Cai

Blood (2011) 118 (21): 5116.

https://doi.org/10.1182/blood.V118.21.5116.5116

Published: 2011

Journal Articles

Retrospective analysis of cytogenetic and clinical characteristics on 65 patients with multiple myeloma

Li Yang, Jingsong He, Xiaojian Meng, Guoqing Wei, Wenjun Wu, Xiaoyan Han, Gaofeng Zheng, Weiyan Zheng, Xiujin Ye, Jimin Shi, Wanzhuo Xie, Jie Zhang, He Huang, Maofang Lin, Zhen Cai

Blood (2011) 118 (21): 5075.

https://doi.org/10.1182/blood.V118.21.5075.5075

Published: 2011

Journal Articles

First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation

Haowen Xiao, Jimin Shi, Yi Luo, Yamin Tan, Jingsong He, Wanzhuo Xie, Lifei Zhang, Yingjia Wang, Lizhen Liu, Kangni Wu, Xiaohong Yu, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang

Blood (2011) 117 (19): 5257–5260.

https://doi.org/10.1182/blood-2010-12-326322

Published: 2011

Includes: Supplemental data

Journal Articles

The Association of the Polymorphisms of IMPDH1 Gene and Acute Graft-Versus-Host Disease After Related and Unrelated Hematopoietic Stem Cell Transplantation

Lifei Zhang, Haowen Xiao, Weijie Cao, Xiaoyu Lai, Yi Luo, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Li Li, Xiaoli Zhu, Jie Sun, Guoqin Wei, Yingjia Wang, Xiaohong Yu, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang, MD, PhD

Blood (2010) 116 (21): 2377.

https://doi.org/10.1182/blood.V116.21.2377.2377

Published: 2010

Journal Articles

The Genotype of T-Cell Costimulatory Molecule Is Associated with Relapse Incidence In Patients with Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation

Haowen Xiao, Xiaoyu Lai, Yi Luo, Jimin Shi, Yamin Tan, Jingsong He, Wanzhuo Xie, Lifei Zhang, Yingjia Wang, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang, MD, PhD

Blood (2010) 116 (21): 684.

https://doi.org/10.1182/blood.V116.21.684.684

Published: 2010

Journal Articles

Combination Therapy Based on Bortezomib for Newly-Diagnosed Multiple Myeloma: a Chinese Experience

Li Yang, Jing-Song He, WenJun Wu, Xiujin Ye, Jimin Shi, Jie Zhang, Wanzhuo Xie, Xiaoyan Han, Gaofeng Zheng, Guoqing Wei, MD, PhD, Li Li, Jingjing Zhu, Xiaoli Zhu, Weijia Huang, Xiaojian Meng, He Huang, MD, PhD, Maofang Lin, Zhen Cai

Blood (2010) 116 (21): 5036.

https://doi.org/10.1182/blood.V116.21.5036.5036

Published: 2010

Journal Articles

“Back-up” Stem Cell Harvest Is Beneficial for Patients Receiving Unrelated Donor Allogeneic Hematopoietic Cell Transplantation.

Huarui Fu, Yamin Tan, Yi Luo, Yanlong Zheng, Jimin Shi, Jingsong He, Wenjun Wu, Jie Sun, Li Li, Xiaoyan Han, Xiaoli Zhu, Shuiyun Chen, Zhen Cai, Xiujin Ye, Wanzhou Xie, Jie Zhang, Maofang Lin, He Huang, MD, PhD

Blood (2010) 116 (21): 4524.

https://doi.org/10.1182/blood.V116.21.4524.4524

Published: 2010

Journal Articles

Evaluation the Risk Factor of Transplantation-Associated Thrombotic Microangiopathy.

Weiyan Zheng, Yi Luo, Yamin Tan, Jingsong He, Jimin Shi, Guoqin Wei, Jie Sun, Xiujin Ye, Maofang Lin, Zhen Cai, He Huang, MD, PhD

Blood (2010) 116 (21): 4527.

https://doi.org/10.1182/blood.V116.21.4527.4527

Published: 2010

NARROW

Iron Metabolism before Allo-HSCT in Patients with Acute Leukemia and Impact of Iron Overload on Transplantation

Imatinib Combined with Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Versus Imatinib Alone for Young Patients with Chronic Myeloid Leukemia in Chronic Phase

Serem Ferritin Was the Only Prognostic Factor for Disease Free Survival in MDS Patients after Allo-HSCT: A Single Centre Study

Relationship between Gene Polymorphism of Recipient/ Donor Immune Pathway and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

Clinical Outcome Of R-CHOP Or CHOP Regimen For Elderly Patients With Diffuse Large B-Cell Lymphoma In China：A Single Center’s Experience

Prospective Evaluation Of Allo-HSCT From Haploidentical-Related Donors Compared With Matched Sibling Donors and Unrelated Donors For Patients With Hematological Malignancies: Results From An Open-Label Trial

Clinical Characteristics and Outcome of Isolated Extramedullary Relapse in Acute Leukemia Following Allogeneic Stem Cell Transplantation: A Single Institutional Analysis

Significance of Clinical Factors As Prognostic Indicators for Mature T-Cell Non-Hodgkin Lymphoma Patients: A Retrospective Analysis of Chinese Cases

Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients

Donor Toll-Like Receptor 9 Genetic Factors in Susceptibility to Acute Graft-Versus-Host Disease and Cytomegalovirus Infection After Related and Unrelated Hematopoietic Stem Cell Transplantation

Genetic Variation in the Effector Pathways of Cytotoxic T Lymphocytes Influences Alloimmune Reactivities Following Allogeneic Hematopoietic Stem Cell Transplantation

Combination therapy based on bortezomib for 102 patients with newly-diagnosed multiple myeloma: a Chinese experience

Retrospective analysis of cytogenetic and clinical characteristics on 65 patients with multiple myeloma

First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation

The Association of the Polymorphisms of IMPDH1 Gene and Acute Graft-Versus-Host Disease After Related and Unrelated Hematopoietic Stem Cell Transplantation

The Genotype of T-Cell Costimulatory Molecule Is Associated with Relapse Incidence In Patients with Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation

Combination Therapy Based on Bortezomib for Newly-Diagnosed Multiple Myeloma: a Chinese Experience

“Back-up” Stem Cell Harvest Is Beneficial for Patients Receiving Unrelated Donor Allogeneic Hematopoietic Cell Transplantation.

Evaluation the Risk Factor of Transplantation-Associated Thrombotic Microangiopathy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only